Single-Dose Oral Influenza Antiviral Prodrug Enabled by Cholesterol Conjugation
Chenning Li(Chinese Academy of Sciences), Xuebing Li(Tianjin Medical University General Hospital), Lifeng Fu(Chinese Academy of Sciences), Yiran Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuihong Cheng(Chinese Academy of Sciences), Chenxi Cheng(Shenyang Pharmaceutical University), Yuhai Bi(Chinese Academy of Sciences), Xun Lv(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences)
Cited by 0
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k